{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences Hits Day High with Strong 5.45% Intraday Surge
PharmaBlock Sciences (Nanjing), Inc. saw a notable increase on July 10, 2026, contrasting with a decline in the China Shanghai Composite. Despite recent gains, the company has faced challenges, including a negative annual return and decreased profits, while its market capitalization stands at CNY 5,989 million.
PharmaBlock Sciences Hits Day High with 7.97% Surge in Stock Price
PharmaBlock Sciences (Nanjing), Inc. saw a notable increase in its stock performance on June 29, 2026, achieving an intraday high. Despite recent gains, the company's year-to-date performance remains negative, and its long-term outlook shows mixed results, reflecting a challenging market environment.
PharmaBlock Sciences Hits Day Low of CNY 32.80 Amid Price Pressure
PharmaBlock Sciences (Nanjing), Inc. saw a notable decline in its stock today, contrasting with the broader market's performance. Over recent weeks and months, the stock has faced significant losses, reflecting ongoing challenges. Despite this, the company retains a market capitalization of CNY 7,711 million and a price-to-earnings ratio of 49.00.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
